News About: Pharm. Industry
There raising claim that new drugs do not receive a reasonable price in the process of registering domestic new drug list
Pharmaceutical manufacturers industry is claiming that due to the institutional irrationalism, there are increasing cases which get an unkind treatment in the process of registering domestic new drug list. They explai...
Domestic pharmaceutical companies are enhancing the patent team personnel in order to prepare Drug Approval-Patent Linkage System
Domestic pharmaceutical companies are enhancing the patent team personnel in order to prepare Drug Approval-Patent Linkage System which takes effect from next year.
On May 15, an official from pharmaceutical company ...
Health Insurance Policy Review Committee decided partial insurance restriction of Stillen
On May 14, Ministry of Health and Welfare held Health Insurance Policy Review Committee and discussed health insurance benefit restriction of Stillen with indication 'Prevention of Gastritis due to NSAIDs'. The result...
The number of OTC wholesaler companies keeps decreasing, and it is expected to have harmful effect on not only wholesaler industry but also pharmaceutical manufacturer industry and pharmacy
On May 14, according to pharmaceutical manufacturer and wholesaler society, if the number of OTC wholesaler companies keeps decreasing, it is expected to have harmful effect on not only wholesaler industry but also ph...
There is no big difference between the price of Forxiga and DPP-4 inhibitors
On May 14, according to the related industry, AstraZeneca got healthcare insurance benefit approval of SGLT-2 inhibitor 'Forxiga (dapagliflozin)' from Health Insurance Review & Assessment, drug insurance benefit Asses...
It will be effective to enter first generic business in the U.S. making use of strategy to avoid invalidity of patent or evasion of patent
Team manager of Boryung Pharmaceutical patent team Kim Kwang-Bum, wrote for a 'KPMA Brief' first issue (the May issue) which is released from Korean Pharmaceutical Manufacturers Association with the topic of 'Overview...
Drug Approval-Patent Linkage System is introduced in March 2015
Drug Approval-Patent Linkage System is introduced in March 2015. As Drug Approval-Patent Linkage System conducts, generic developer cannot apply for permission of generic drug without the consent of the original devel...
It was reported that 5 companies including JW Joongwae, Ahngook Pharmaceutical, and Kwangdong Pharmaceutical have entered a bidding battle for DreamPharma
It was reported that 5 companies including JW Joongwae, Ahngook Pharmaceutical, and Kwangdong Pharmaceutical have entered a bidding battle for DreamPharma.
There are some opinions that in case of JW Joongwae, it woul...
GSK recently made the decision to resume the domestic promotional activities of diabetes treatment 'Avandia'
On May 12, according to the related pharmaceutical industry, GSK recently made the decision to resume the domestic promotional activities of diabetes treatment 'Avandia' (rosiglitazone), and plans to assign personnel ...
Korea Health Industry Development Institute has recently released "Japanese pharmaceutical companies' research and development situation analysis • comparison report"
Korea Health Industry Development Institute has recently released "Japanese pharmaceutical companies' research and development situation analysis • comparison report". They announced that Japanese pharmaceutical indus...
